DG
Daventry Group’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-106,823
| Closed | -$21M | – | 10 |
|
|
2024
Q3 | $21M | Sell |
106,823
-12,872
| -11% | -$2.54M | 8.37% | 6 |
|
|
2024
Q2 | $24.7M | Buy |
119,695
+4,033
| +3% | +$833K | 11.04% | 4 |
|
|
2024
Q1 | $31.3M | Buy |
115,662
+4,500
| +4% | +$1.22M | 12.53% | 3 |
|
|
2023
Q4 | $26.3M | Buy |
111,162
+32,554
| +41% | +$7.7M | 11.28% | 5 |
|
|
2023
Q3 | $15.4M | Buy |
78,608
+6,985
| +10% | +$1.37M | 9.82% | 6 |
|
|
2023
Q2 | $15.1M | Buy |
71,623
+8,500
| +13% | +$1.79M | 11.15% | 7 |
|
|
2023
Q1 | $12.7M | Buy |
+63,123
| New | +$12.7M | 8.91% | 7 |
|